Scientists have developed a DNA nanoflower that delivers chemotherapy and gene therapy directly to breast cancer cells, boosting effectiveness while reducing side effects in early tests.
Breast cancer continues to be one of the most prevalent cancers worldwide. Although drugs like Doxorubicin (DOX) are commonly used, their effectiveness is often limited by toxicity, poor targeting, and the development of multi-drug resistance. DNA nanostructures, due to their biocompatibility and programmability, are gaining attention as more precise delivery vehicles.
Researchers have created a new DNA nanoflower-based drug delivery system capable of co-delivering an antisense oligonucleotide (ASO) and the chemotherapy drug DOX.
Published in Micro & Nano Letters, the study demonstrates how they used a dual amplification method to form a flower-shaped DNA nanostructure with a high drug-loading capacity and highly targeted delivery.
This study focuses on tackling the limitations of traditional DOX-based therapies by combining gene silencing and chemotherapy into one delivery system. The DNA nanoflowers are also functionalised with AS1411, an aptamer that binds to nucleolin (a protein overexpressed on many tumour cells), improving targeting accuracy.
Building the DNA Nanoflower
The research team used a two-step amplification process to construct the nanoflowers. First, they used rolling circle amplification with Phi29 DNA polymerase to produce long single-stranded DNA sequences with repeating units. These sequences were then further amplified using multiplexed enzyme amplification, forming the unique nanoflower structure.
Specific sequences were engineered into the DNA scaffold to carry both the ASO and DOX drugs. ASO targeted PLK1, a gene associated with cancer cell growth and division, while DOX was intercalated directly into the DNA structure, making use of its natural affinity for DNA bases.
The AS1411 aptamer was conjugated to the nanostructure to enable tumour-specific targeting. The team confirmed the structure’s size, morphology, and successful functionalisation using a range of analytical techniques, including transmission electron microscopy, dynamic light scattering, and gel electrophoresis.
In Vitro and In Vivo Testing
In vitro experiments were carried out using MCF-7 breast cancer cells to assess cellular uptake, gene silencing, cytotoxicity, apoptosis, and cell migration. The researchers used flow cytometry, CCK-8 assays, qRT-PCR, western blotting, and Transwell migration assays to evaluate these parameters.
The in vivo phase of the study used nude mice implanted with MCF-7 cells to form breast tumours. Once tumours had developed, mice were treated locally with the nanoflower formulations.
Promising Results in Early Tests
Analysis of the DNA nanoflowers showed their high drug-loading efficiency and their uniform, flower-like shape. The aptamer-functionalised structures showed significantly enhanced uptake in cancer cells compared to non-targeted controls.
In lab tests, the nanoflower carrying both ASO and DOX (referred to as DNF-ASO@DOX) reduced tumour cell proliferation and triggered apoptosis more effectively than either DOX or ASO alone. The ASO silenced PLK1 expression, confirmed at both the mRNA and protein levels, and resulted in cell cycle arrest and increased cell death.
The system allowed for controlled drug release in response to enzymatic signals, specifically FEN1, which is overexpressed in tumour cells. This meant the active agents were mainly released at the tumour site, minimising damage to healthy tissue.
In animal studies, tumours treated with DNF-ASO@DOX showed markedly reduced growth. Tissue analysis revealed higher levels of apoptosis and lower PLK1 expression in tumour cells. Blood tests and organ inspections indicated minimal systemic toxicity, supporting the biocompatibility of the nanoflower platform.
Looking Ahead
The study highlights the potential of DNA nanoflowers as a new kind of combination therapy tool, able to deliver both genetic and chemotherapeutic treatments in a highly targeted way. With its tumour-specific binding and controlled release mechanisms, the platform could offer a new route to overcome issues like multi-drug resistance and off-target side effects that currently limit breast cancer treatments.
Journal Reference
Shen X., Zhu A., et al. (2025). DNA Nanoflower Enables Controlled Co-Delivery of Antisense Oligodeoxynucleotide and Doxorubicin for Anti-Breast Cancer Treatment. Micro & Nano Letters. DOI: 10.1002/mnnl.202500008, https://ietresearch.onlinelibrary.wiley.com/doi/10.1049/mna2.70008
News
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]
Scientists Have Discovered These Deadly Parasites Are Secretly Swapping DNA
Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread. A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than [...]
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]
What Bundibugyo Ebola vaccines and treatments are under development
By Mariam Sunny and Jennifer Rigby May 29 (Reuters) – Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the [...]
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]
New Vitamin B12-Based Therapy Could Change How Brain Cancer Is Treated
Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had [...]
Simple Fiber Supplement Cuts Knee Arthritis Pain in Just 6 Weeks, Study Finds
A daily inulin supplement may help reduce knee osteoarthritis pain while revealing a possible link between gut health, muscle function, and pain sensitivity. For millions of people living with knee osteoarthritis, managing chronic pain [...]
This Common Vitamin May Help Stop Prediabetes From Turning Into Diabetes
Vitamin D may help prevent type 2 diabetes in people with specific genetic variations, offering a possible path toward personalized diabetes prevention. More than 40% of U.S. adults have prediabetes, a condition in which [...]
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
